Initial diagnostic panel for skin and mucous membrane disorders that present with blistering, erosions, eczema, pruritus, and/or urticaria, including pemphigoid, pemphigoid variants, epidermolysis bullosa acquisita, linear IgA bullous dermatosis, linear IgA disease variants, and IgG-pemphigus subtypes. Order concurrently with Cutaneous Direct Immunofluorescence, Biopsy (0092572) for initial diagnosis. Use for disease monitoring with semiquantitative antibody level assessments and tracking and for persistent unexplained disease and/or worsening disease activity.
Indirect Fluorescent Antibody/Enzyme-Linked Immunosorbent Assay
Plain Red or Serum Separator Tube (SST).
Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Hemolyzed or Lipemic specimens. Plasma
Ambient: 1 week; Refrigerated: 2 weeks; Frozen: Indefinitely
Refer to report
No compliance statements are in use for this test.
For specimens less than 0.5 mL, call the Immunodermatology Laboratory at (866) 266-5699.
88346; 88350 x5; 83516 x5
|Component Test Code*||Component Chart Name||LOINC|
|3001665||Immunobullous Disease Panel|
|3001666||EER Immunobullous Disease Panel|